Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Natural toxins (Print)

• Publication date

  2006-05-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/(SICI)(1996)4:6<284::AID-NT6>3.0.CO;2-ZPMID 9029554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Human biomonitoring of mycotoxins: key challenges and future directions

  2025cites this paper
• Human Biomonitoring of Selected Hazardous Compounds in Portugal: Part II—Lessons Learned on Mycotoxins

  2021influential citation
• Validation of urinary sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children

  2019cites this paper
• Pedobacter mongoliensis sp. nov., isolated from grassland soil.

  2018cites this paper
• Fourier Transform Mass Spectrometry and Nuclear Magnetic Resonance Analysis for the Rapid and Accurate Characterization of Hexacosanoylceramide

  2016cites this paper
• Fumonisin biomarkers in maize eaters and implications for human disease

  2013cites this paper
• Fumonisin exposure biomarkers in humans consuming maize staple diets

  2011cites this paper
• Sphinganine and sphingosine levels and ratio in urine and blood samples from a Catalonian population, Spain

  2011cites this paper
• Biomonitoring of Fusarium spp. Mycotoxins: Perspectives for an Individual Exposure Assessment Tool

  2010cites this paper
• Mycotoxins and human disease: a largely ignored global health issue.

  2010cites this paper
• Toxicokinetics and toxicological effects of single oral dose of fumonisin B1 containing Fusarium verticillioides culture material in weaned piglets.

  2010cites this paper
• Sphinganine-sphingosine ratio in urine from two Portuguese populations as biomarker to fumonisins exposure.

  2009cites this paper
• Evaluation of Sphingolipids in Wistar Rats Treated to Prolonged and Single Oral Doses of Fumonisin B1

  2008cites this paper
• Sphingoid base levels in humans consuming fumonisin-contaminated maize in rural areas of the former Transkei, South Africa: a cross-sectional study

  2008cites this paper
• Fumonisin exposure and the sphinganine/sphingosine ratio in urine, serum and buccal cells in adults from Burkina Faso, West Africa

  2008cites this paper
• Effects of oral administration of aflatoxin B1 and fumonisin B1 in rabbits (Oryctolagus cuniculus).

  2007cites this paper
• Biomarkers of exposure to fumonisin mycotoxins: A review

  2007cites this paper
• Biomarker in the detection of fumonisin toxicosis in pigs.

  2006cites this paper
• UNIVERSIDAD DE GUADALAJARA CENTRO UNIVERSITARIO DE CIENCIAS BIOLÓGICAS Y AGROPECUARIAS DIVISIÓN DE CIENCIAS VETERINARIAS POSGRADO INTERINSTITUCIONAL EN CIENCIAS PECUARIAS

  2005cites this paper
• Comparison of urinary sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure

  2004influential citation
• Derivatization of phospholipids.

  2003cites this paper
• Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase.

  2002cites this paper
• Comparative study of naphthalene-2,3-dicarboxaldehyde and o-phthalaldehyde fluorogenic reagents for chromatographic detection of sphingoid bases.

  2002cites this paper
• An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials

  2001cites this paper
• The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1

  2001cites this paper
• The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys.

  2001cites this paper
• Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1

  2001influential citation
• A critical assessment of some biomarker approaches linked with dietary intake

  2001cites this paper
• Discovery and occurrence of the fumonisins: a historical perspective.

  2001cites this paper
• A cross-sectional study of human serum sphingolipids, diet and physiologic parameters.

  2001cites this paper
• The effect of a single gavage dose of fumonisin B(1) on the sphinganine and sphingosine levels in vervet monkeys.

  2001cites this paper
• Purification of sphingolipid classes by solid-phase extraction with aminopropyl and weak cation exchanger cartridges.

  2000cites this paper
• Analysis of sphingoid bases and sphingoid base 1-phosphates by high-performance liquid chromatography.

  2000cites this paper
• Improved fluorescent determination method of cellular sphingoid bases in high-performance liquid chromatography

  1999cites this paper
• Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.

  1999cites this paper
• Activation of mitogen-activated protein kinase by fumonisin B(1) stimulates cPLA(2) phosphorylation, the arachidonic acid cascade and cAMP production.

  1999cites this paper
• Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa.

  1999cites this paper
• Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.

  1999cites this paper
• Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure.

  1998cites this paper
• Liquid chromatographic determination of the sphinganine/sphingosine ratio in serum.

  1998cites this paper
• In Vivo Validation of The Sphinganine/Sphingosine Ratio as a Biomarker to Display Fumonisin Ingestion

  1997cites this paper
• Mycotoxins and Human Disease: a Largely Ignored Global Health Issue

  year unknowncites this paper